These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Study of dopamine and noradrenaline in the brains of three patients with Parkinson's disease who died in the course of treatment with L-dopa]. Buscaino GA, Sori A, Campanella G. Rev Neurol (Paris); 1972 Aug; 127(2):301-2. PubMed ID: 4666634 [No Abstract] [Full Text] [Related]
25. Effects of L-dopa administration of the concentrations of dopa, dopamine and norepinephrine in various rat tissues. Romero JA, Lytle LD, Ordonez LA, Wurtman RJ. J Pharmacol Exp Ther; 1973 Jan; 184(1):67-72. PubMed ID: 4686016 [No Abstract] [Full Text] [Related]
26. Levels of norepinephrine and dopamine in mouse brain regions following microwave inactivation--rapid post-mortem degradation of striatal dopamine in decapitated animals. Blank CL, Sasa S, Isernhagen R, Meyerson LR, Wassil D, Wong P, Modak AT, Stavinoha WB. J Neurochem; 1979 Jul; 33(1):213-9. PubMed ID: 37287 [No Abstract] [Full Text] [Related]
29. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. Glowinski J, Iversen LL. J Neurochem; 1966 Aug; 13(8):655-69. PubMed ID: 5950056 [No Abstract] [Full Text] [Related]
30. Dopaminergic nervous transmission in Parkinson's disease. Rinne UK, Sonninen V, Riekkinen P, Laaksonen H. Med Biol; 1974 Jun; 52(3):208-17. PubMed ID: 4371255 [No Abstract] [Full Text] [Related]
33. The interaction between different metabolic pathways of catecholamines in the brain studied by means of 3H-DOPA. Persson T, Waldeck B. Acta Pharmacol Toxicol (Copenh); 1969 May; 27(2):225-36. PubMed ID: 5819576 [No Abstract] [Full Text] [Related]
34. ON FORMATION OF NORADRENALINE IN THE SKIN: ACTIVITY OF DOPAMINE-BETA-OXIDASE. MOELLER H. Acta Derm Venereol; 1963 May; 43():548-51. PubMed ID: 14088645 [No Abstract] [Full Text] [Related]
35. The occurrence of biogenic monoamines in the mammalian endocrine pancreas. Cegrell L. Acta Physiol Scand Suppl; 1968 May; 314():1-60. PubMed ID: 4973243 [No Abstract] [Full Text] [Related]
37. Catecholamine metabolism in the brains of ageing male mice. Finch CE. Brain Res; 1973 Mar 30; 52():261-76. PubMed ID: 4700706 [No Abstract] [Full Text] [Related]
38. The depression of sensitivity to noradrenaline caused by L-dopa. Eden E, Nasmyth PA. J Physiol; 1973 Apr 30; 230(1):7P-8P. PubMed ID: 4702454 [No Abstract] [Full Text] [Related]
39. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates. Ng LK, Colburn RW, Kopin IJ. J Pharmacol Exp Ther; 1972 Nov 30; 183(2):316-25. PubMed ID: 5083548 [No Abstract] [Full Text] [Related]
40. Letters to the editor: New principles for microspectrofluorometric differentiation between DOPA, dopamine and noradrenaline. Lindvall O, Björklund A, Falck B, Svensson LA. J Histochem Cytochem; 1975 Sep 30; 23(9):697-9. PubMed ID: 1176763 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]